Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI

類似資料

• Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA score
  著者:: Liu, Yongmei, 等
  出版事項: (2017)
• Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report
  著者:: Jing, Wei, 等
  出版事項: (2020)
• Deep learning on brain metastasis for predicting EGFR genotype and EGFR-TKI therapy response in metastatic NSCLC: a multicenter study
  著者:: Shuailin You, 等
  出版事項: (2025-10-01)
• Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
  著者:: Chen, Hongjin, 等
  出版事項: (2021)
• Efficacy of epidermal growth factor receptor–tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports
  著者:: Liu, Yongmei, 等
  出版事項: (2017)